Clinical Assessment of Orofacial Manifestations in 500 Patients With Multiple Sclerosis

Saved in:
Bibliographic Details
Title: Clinical Assessment of Orofacial Manifestations in 500 Patients With Multiple Sclerosis
Authors: Navid Haghdoost, Somayyeh Sabzali-Zanjankhah, Seyed Amir Danesh-Sani, Ali Rahimdoost, Mohammad Ghiyasi, Mahmood Soltani
Source: Journal of Oral and Maxillofacial Surgery. 71:290-294
Publisher Information: Elsevier BV, 2013.
Publication Year: 2013
Subject Terms: Adult, Male, Neurologic Examination, Multiple Sclerosis, Time Factors, Adolescent, Dysarthria, Incidence, Facial Paralysis, Vision Disorders, Iran, Middle Aged, Temporomandibular Joint Disorders, Trigeminal Neuralgia, 3. Good health, 03 medical and health sciences, 0302 clinical medicine, Humans, Drug Interactions, Female, Child, Deglutition Disorders, Aged
Description: The aim of the present study was to determine the incidence of orofacial manifestations in patients with multiple sclerosis (MS) and to assess the factors associated with these symptoms. The dental implications of this disease are discussed.The study included 500 patients 11 to 69 years old with MS. All patients underwent a standard neurologic examination. The main manifestations assessed by the investigators were trigeminal neuralgia, facial palsy, temporomandibular disorders, visual complications, dysphagia, and dysarthria. The authors collected demographic information and clinical variables, such as disease duration and family history, to assess the factors associated with orofacial symptoms in patients with MS.The frequency of orofacial manifestations in patients with MS was 88.6%. Visual disorders (80.4%) were observed most frequently in patients with MS, followed by temporomandibular disorders (58.2%), dysarthria (42.1%), dysphagia (26.6%), facial palsy (19%), and trigeminal neuralgia (7.9%). A significant correlation with orofacial manifestations was found in patients with a longer duration of disease (>7 yr) compared with patients with a shorter duration (
Document Type: Article
Language: English
ISSN: 0278-2391
DOI: 10.1016/j.joms.2012.05.008
Access URL: https://pubmed.ncbi.nlm.nih.gov/22742955
https://www.sciencedirect.com/science/article/abs/pii/S0278239112006519
http://www.sciencedirect.com/science/article/pii/S0278239112006519
http://europepmc.org/abstract/MED/22742955
https://www.ncbi.nlm.nih.gov/pubmed/22742955
https://pubmed.ncbi.nlm.nih.gov/22742955/
Rights: Elsevier TDM
Accession Number: edsair.doi.dedup.....4b51a902f69857527ceb3f408a1cb7a6
Database: OpenAIRE
Description
Abstract:The aim of the present study was to determine the incidence of orofacial manifestations in patients with multiple sclerosis (MS) and to assess the factors associated with these symptoms. The dental implications of this disease are discussed.The study included 500 patients 11 to 69 years old with MS. All patients underwent a standard neurologic examination. The main manifestations assessed by the investigators were trigeminal neuralgia, facial palsy, temporomandibular disorders, visual complications, dysphagia, and dysarthria. The authors collected demographic information and clinical variables, such as disease duration and family history, to assess the factors associated with orofacial symptoms in patients with MS.The frequency of orofacial manifestations in patients with MS was 88.6%. Visual disorders (80.4%) were observed most frequently in patients with MS, followed by temporomandibular disorders (58.2%), dysarthria (42.1%), dysphagia (26.6%), facial palsy (19%), and trigeminal neuralgia (7.9%). A significant correlation with orofacial manifestations was found in patients with a longer duration of disease (>7 yr) compared with patients with a shorter duration (
ISSN:02782391
DOI:10.1016/j.joms.2012.05.008